BBH vs. BBC
Compare and contrast key facts about VanEck Vectors Biotech ETF (BBH) and Virtus LifeSci Biotech Clinical Trials ETF (BBC).
BBH and BBC are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. BBH is a passively managed fund by VanEck that tracks the performance of the MVIS US Listed Biotech 25 Index. It was launched on Dec 20, 2011. BBC is a passively managed fund by Virtus Investment Partners that tracks the performance of the LifeSci Biotechnology Clinical Trials Index. It was launched on Dec 16, 2014. Both BBH and BBC are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BBH or BBC.
Correlation
The correlation between BBH and BBC is 0.52, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
BBH vs. BBC - Performance Comparison
Key characteristics
BBH:
-0.23
BBC:
-0.71
BBH:
-0.19
BBC:
-0.85
BBH:
0.98
BBC:
0.90
BBH:
-0.13
BBC:
-0.36
BBH:
-0.53
BBC:
-1.30
BBH:
8.53%
BBC:
21.41%
BBH:
19.63%
BBC:
39.03%
BBH:
-72.69%
BBC:
-76.85%
BBH:
-31.30%
BBC:
-70.00%
Returns By Period
In the year-to-date period, BBH achieves a -5.20% return, which is significantly higher than BBC's -23.46% return. Over the past 10 years, BBH has outperformed BBC with an annualized return of 1.92%, while BBC has yielded a comparatively lower -5.17% annualized return.
BBH
-5.20%
-6.37%
-12.26%
-3.09%
0.32%
1.92%
BBC
-23.46%
-2.16%
-36.57%
-25.07%
-12.40%
-5.17%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BBH vs. BBC - Expense Ratio Comparison
BBH has a 0.35% expense ratio, which is lower than BBC's 0.79% expense ratio.
Risk-Adjusted Performance
BBH vs. BBC — Risk-Adjusted Performance Rank
BBH
BBC
BBH vs. BBC - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Vectors Biotech ETF (BBH) and Virtus LifeSci Biotech Clinical Trials ETF (BBC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BBH vs. BBC - Dividend Comparison
BBH's dividend yield for the trailing twelve months is around 0.84%, less than BBC's 1.31% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
BBH VanEck Vectors Biotech ETF | 0.84% | 0.80% | 0.43% | 0.47% | 0.21% | 0.36% | 0.34% | 0.50% | 0.55% | 0.30% | 0.27% |
BBC Virtus LifeSci Biotech Clinical Trials ETF | 1.31% | 1.00% | 0.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.04% | 0.00% | 0.51% |
Drawdowns
BBH vs. BBC - Drawdown Comparison
The maximum BBH drawdown since its inception was -72.69%, smaller than the maximum BBC drawdown of -76.85%. Use the drawdown chart below to compare losses from any high point for BBH and BBC. For additional features, visit the drawdowns tool.
Volatility
BBH vs. BBC - Volatility Comparison
The current volatility for VanEck Vectors Biotech ETF (BBH) is 11.42%, while Virtus LifeSci Biotech Clinical Trials ETF (BBC) has a volatility of 19.99%. This indicates that BBH experiences smaller price fluctuations and is considered to be less risky than BBC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.